Related references
Note: Only part of the references are listed.Intratumoral COX-2 inhibition enhances GM- CSF immunotherapy against established mouse GL261 brain tumors
Sofia Eberstal et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Sorbitol Dehydrogenase Overexpression and Other Aspects of Dysregulated Protein Expression in Human Precancerous Colorectal Neoplasms: A Quantitative Proteomics Study
Anuli Uzozie et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
O-GlcNAcylation Regulates Cancer Metabolism and Survival Stress Signaling via Regulation of the HIF-1 Pathway
Christina M. Ferrer et al.
MOLECULAR CELL (2014)
FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data
Elzbieta Zodro et al.
TUMOR BIOLOGY (2014)
Hypoxia enhances lipid uptake in macrophages: Role of the scavenger receptors Lox1, SRA, and CD36
Margot Crucet et al.
ATHEROSCLEROSIS (2013)
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer
Melis Kartal Yandim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress
Kenshi Suzuki et al.
NEURO-ONCOLOGY (2013)
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
Chunzhi Zhang et al.
NEURO-ONCOLOGY (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development
Paulina Kucharzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma
Marwa E. Elsherbiny et al.
PROGRESS IN LIPID RESEARCH (2013)
SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
Petra Simic et al.
CELL REPORTS (2013)
The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism
Prakash Chinnaiyan et al.
CANCER RESEARCH (2012)
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells
Elena Favaro et al.
CELL METABOLISM (2012)
Sphingolipid Signaling in Metabolic Disorders
Timothy Hla et al.
CELL METABOLISM (2012)
Regulation of cholesterol biosynthesis and cancer signaling
Andrey Gorin et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Lipid metabolism in cancer
Claudio R. Santos et al.
FEBS JOURNAL (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival
Joffrey Pelletier et al.
FRONTIERS IN ONCOLOGY (2012)
The NAD metabolome - a key determinant of cancer cell biology
Alberto Chiarugi et al.
NATURE REVIEWS CANCER (2012)
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Lydia W. S. Finley et al.
CANCER CELL (2011)
O-GlcNAc transferase A sweet new cancer target
Thomas P. Lynch et al.
CELL CYCLE (2011)
Targeting Aldose Reductase for the Treatment of Cancer
R. Tammali et al.
CURRENT CANCER DRUG TARGETS (2011)
Aldose Reductase Inhibition Prevents Hypoxia-induced Increase in Hypoxia-inducible Factor-1α (HIF-1α) and Vascular Endothelial Growth Factor (VEGF) by Regulating 26 S Proteasome-mediated Protein Degradation in Human Colon Cancer Cells (Publication with Expression of Concern. See vol. 294, pg. 1634, 2019)
Ravinder Tammali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
E. L. Bell et al.
ONCOGENE (2011)
Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
Christian Frezza et al.
PLOS ONE (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Fructose Induces Transketolase Flux to Promote Pancreatic Cancer Growth
Haibo Liu et al.
CANCER RESEARCH (2010)
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Lei Zhong et al.
CELL (2010)
The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells
Li-Ying Wu et al.
CELL STRESS & CHAPERONES (2010)
Altered sphingolipid metabolism induced by tumor hypoxia - New vistas in glycolipid tumor markers
Jun Yin et al.
FEBS LETTERS (2010)
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Ji-Hong Lim et al.
MOLECULAR CELL (2010)
Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas
Jaekyung Myung et al.
NEUROPATHOLOGY (2010)
Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems
Anne M. Evans et al.
ANALYTICAL CHEMISTRY (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats
Tetsuya Ohta et al.
TOXICOLOGIC PATHOLOGY (2009)
Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase
Katrin J. Svensson et al.
CANCER RESEARCH (2008)
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-lot signaling in a human prostate cancer model
Kristine Glunde et al.
CANCER RESEARCH (2008)
Ceramide triggers budding of exosome vesicles into multivesicular Endosomes
Katarina Trajkovic et al.
SCIENCE (2008)
Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs
Andrew D. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Hiroshi Nawashiro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol
BL Song et al.
CELL METABOLISM (2005)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates
T Koike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Aldose reductase and the role of the polyol pathway in diabetic nephropathy
M Dunlop
KIDNEY INTERNATIONAL (2000)
Share Paper
